COM:GEHEALTHCARE
GE HealthCare
- Stock
Last Close
82.00
22/11 21:00
Market Cap
36.12B
Beta: -
Volume Today
5.31M
Avg: -
Preview
Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page
Dec '19 | Dec '20 | Dec '21 | Dec '22 | Dec '23 | ||
|---|---|---|---|---|---|---|
average inventory | 1.77B - | 2.05B 15.85% | 2.06B 0.34% | |||
average payables | 2.35B - | 2.74B 16.63% | 2.95B 7.42% | |||
average receivables | 3.22B - | 4.05B 25.50% | 3.91B 3.29% | |||
book value per share | 32.39 - | 36.63 13.09% | 20.61 43.73% | 15.68 23.93% | ||
capex per share | -0.73 - | -0.57 21.75% | -0.55 4.25% | -0.68 25.19% | -0.85 24.57% | |
capex to depreciation | -0.50 - | -0.41 18.15% | -0.40 3.48% | -0.49 23.42% | -0.63 29.55% | |
capex to operating cash flow | -0.17 - | -0.15 7.74% | -0.15 0.52% | -0.15 4.93% | -0.17 12.82% | |
capex to revenue | -0.02 - | -0.02 24.17% | -0.01 6.54% | -0.02 19.85% | -0.02 17.11% | |
cash per share | 2.19 - | 1.22 44.27% | 3.18 161.22% | 5.50 72.92% | ||
days of inventory on hand | 55.96 - | 68.22 21.92% | 70.47 3.29% | 61.51 12.71% | ||
days payables outstanding | 75.90 - | 89.05 17.33% | 96.27 8.11% | 92.49 3.93% | ||
days sales outstanding | 56.50 - | 78.69 39.26% | 85.59 8.78% | 65.81 23.12% | ||
debt to assets | 0.02 - | 0.02 14.01% | 0.30 1,703.26% | 0.29 2.87% | ||
debt to equity | 0.03 - | 0.03 17.43% | 0.88 3,259.91% | 1.32 50.15% | ||
dividend yield | 0.00 - | |||||
earnings yield | 0.06 - | 0.08 35.04% | 0.08 9.18% | 0.07 12.23% | 0.09 22.06% | |
enterprise value | 26.76B - | 27.17B 1.53% | 33.31B 22.62% | 42.12B 26.44% | ||
enterprise value over ebitda | 7.86 - | 7.67 2.31% | 10.34 34.72% | 17.30 67.31% | ||
ev to operating cash flow | 15.86 - | 16.90 6.58% | 15.76 6.74% | 18.01 14.28% | ||
ev to sales | 1.56 - | 1.54 0.90% | 1.82 17.56% | 2.15 18.61% | ||
free cash flow per share | 3.65 - | 3.14 13.87% | 2.99 4.83% | 3.97 32.87% | 4.29 7.98% | |
free cash flow yield | 0.06 - | 0.05 13.87% | 0.05 4.83% | 0.07 36.56% | 0.06 18.47% | |
graham net net | -12.52 - | -11.57 7.58% | -27.37 136.56% | -41.79 52.68% | ||
graham number | 57.43 - | 63.82 11.12% | 44.24 30.68% | 49.05 10.89% | ||
income quality | 1.18 - | 0.82 30.72% | 0.71 13.83% | 1.08 53.48% | 1.45 33.61% | |
intangibles to total assets | 0 - | 0.56 Infinity% | 0.56 0.76% | 0.52 7.10% | 0.44 16.00% | |
interest coverage | 24.14 - | 41.21 70.75% | 69.88 69.55% | 32.75 53.13% | 4.49 86.28% | |
interest debt per share | 1.17 - | 1.05 10.67% | 18.34 1,648.11% | 21.94 19.66% | ||
inventory turnover | 6.52 - | 5.35 17.98% | 5.18 3.18% | 5.93 14.56% | ||
invested capital | 0.03 - | 0.03 17.43% | 0.88 3,259.91% | 1.32 50.15% | ||
market cap | 27.28B - | 27.28B 0% | 27.28B 0% | 26.51B 2.85% | 35.18B 32.73% | |
net current asset value | -3.58B - | -2.63B 26.50% | -9.86B 274.58% | -17.16B 74.00% | ||
net debt to ebitda | -0.15 - | -0.03 78.60% | 2.11 6,489.34% | 2.85 34.93% | ||
net income per share | 3.35 - | 4.53 35.04% | 4.94 9.18% | 4.22 14.60% | 6.82 61.66% | |
operating cash flow per share | 4.37 - | 3.71 15.18% | 3.53 4.74% | 4.65 31.68% | 5.14 10.41% | |
payables turnover | 4.81 - | 4.10 14.77% | 3.79 7.50% | 3.95 4.09% | ||
receivables turnover | 6.46 - | 4.64 28.19% | 4.26 8.07% | 5.55 30.07% | ||
research and ddevelopement to revenue | 0.05 - | 0.05 5.77% | 0.05 1.67% | 0.06 20.55% | 0.06 10.17% | |
return on tangible assets | 0.19 - | 0.19 1.52% | 0.15 25.30% | 0.17 17.13% | ||
revenue per share | 36.58 - | 37.75 3.19% | 38.67 2.45% | 40.40 4.46% | 42.97 6.38% | |
roe | 0.14 - | 0.13 3.46% | 0.20 51.78% | 0.44 112.52% | ||
roic | 0.13 - | 0.13 4.34% | 0.11 13.99% | 0.19 77.59% | ||
sales general and administrative to revenue | ||||||
shareholders equity per share | 32.39 - | 36.63 13.09% | 20.61 43.73% | 15.68 23.93% | ||
stock based compensation to revenue | 0.01 - | -0.05 697.48% | 0.01 - | |||
tangible asset value | 1.28B - | 1.94B 51.33% | -4.97B 356.63% | -6.88B 38.38% | ||
tangible book value per share | 2.81 - | 4.26 51.33% | -10.95 357.02% | -15.12 38.09% | ||
working capital | -628M - | 239M 138.06% | 1.13B 371.55% | -992M 188.02% |
All numbers in (except ratios and percentages)